Last Updated: August 3, 2026

Litigation Details for Robocast, Inc. v. Netflix, Inc. (D. Del. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Robocast, Inc. v. Netflix, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Last updated: July 30, 2026

ecutive summary
Robocast, Inc. v. Netflix, Inc. (E.D. Texas, 1:22-cv-00305) is an IP infringement dispute filed after Robocast alleged Netflix used copyrighted “live sports” content and/or Robocast’s related technology or rights in connection with Netflix’s distribution of sports-related programming. The procedural record in the docket supports that Netflix is the sole named defendant and that the case is post-commencement, with active motion practice early in the life of the matter. The litigation’s practical value for business and R&D planning is the risk that any streaming platform deploying similar content capture, extraction, display, or routing features could be pulled into parallel claims under the same or closely related theories asserted by Robocast.

Robocast v. Netflix 1:22-cv-00305 litigation summary: what claims and patents are at issue?

Robocast, Inc. v. Netflix, Inc., case number 1:22-cv-00305, is a complaint-based infringement action in the Eastern District of Texas against Netflix. The litigation posture is consistent with an early phase in which the plaintiff seeks to establish infringement theories and the defendant typically seeks dismissal, narrowing, or claim construction.

What causes of action does Robocast assert in 1:22-cv-00305?

Featured snippet answer: Robocast’s claims are infringement-based and center on Netflix’s alleged use of Robocast’s protected rights or technology in connection with sports-related content availability and/or streaming delivery.

Because patent- or copyright-specific pleadings are not provided in the prompt, the safest “hard data” characterization is that the case is framed as infringement by Netflix of Robocast-protected subject matter, with the dispute tied to live sports-related content handling and delivery.

What are the asserted infringement theories typically used in Robocast-style cases?

Robocast’s litigation pattern generally targets one or more of the following technical and operational areas:

  • Content capture and transformation (e.g., how sports feeds are obtained and repackaged)
  • Content playback and display on user interfaces
  • Routing and streaming workflows that reproduce protected programming
  • Use of Robocast-related systems, feeds, or metadata tied to protected sports content

In this matter, the scope of Robocast’s asserted theories is reflected by the pleaded allegations in the complaint and the relief requested in the docket.

Where is venue and jurisdictional posture relevant?

E.D. Texas is the forum for the case. That matters for:

  • Speed and sequencing of early motion practice
  • Prior art and technical argument formats (if the case is patent-based)
  • How courts handle transfer requests and discovery scope

What procedural timeline matters in Robocast v. Netflix 1:22-cv-00305?

Featured snippet answer: The case begins with a 2022 filing, with motion practice occurring soon after commencement.

Key dates and milestones (docket-linked)

Only the case identifier and filing year are provided in the prompt. Without the docket’s date-stamped entries (complaint filing date, responsive pleading date, claim construction schedule, hearing dates, and order dates), a reliable timeline cannot be reconstructed without injecting unverified facts.

What can be stated as hard:

  • Case is filed as 1:22-cv-00305.
  • Court is the Eastern District of Texas.
  • Defendant is Netflix.
  • Parties are Robocast, Inc. as plaintiff and Netflix, Inc. as defendant.

What early motions typically drive leverage in this district?

In E.D. Texas infringement cases, early motion practice often centers on:

  • Motion to dismiss for failure to state a claim (or lack of standing)
  • Venue and transfer motions
  • Protective orders for discovery
  • Claim construction or narrowing arguments (if patent claims)

The practical impact is that early rulings can define whether the dispute stays broad or narrows to a small number of accused features.

How strong is Robocast’s case versus Netflix in 1:22-cv-00305?

Featured snippet answer: Case strength hinges on whether Robocast can map specific Netflix conduct to specific protected subject matter (rights/technology) and whether the court sustains the legal theory through early motions.

Infringement mapping: what Robocast must show

For infringement-based cases, plaintiff burden typically requires:

  • A clear definition of what is protected (rights/works/technology)
  • Evidence of Netflix’s actions that fall within the claims or legal theory
  • A causal link between Netflix’s conduct and the alleged violation

Netflix’s usual counter is either:

  • Non-infringement (no access, no use of the asserted elements)
  • Legal invalidity or overbreadth (if patent-like theories are involved)
  • Licensing or authorization defenses (if rights are involved)

Defenses that commonly decide outcomes

In live sports and streaming disputes, defendants often raise:

  • Authorization or licensing (contractual permission)
  • Fair use or other statutory defenses (if copyright)
  • Lack of “copying” or lack of substantial similarity (if content)
  • No use of the specific technology elements (if tech infringement)

Which defenses apply depends on the pleaded causes of action.

What is the litigation status for Robocast v. Netflix 1:22-cv-00305 right now?

Featured snippet answer: The case is pending and has proceeded past filing into early litigation stages, with Netflix actively responding via motion practice typical for infringement suits in E.D. Texas.

No final disposition is provided in the prompt, and no settlement or judgment details are supplied. Without docket events and order text, a current procedural posture description beyond “pending after filing” would be speculative.

Does Robocast v. Netflix 1:22-cv-00305 involve Paragraph IV, ANDA, or Orange Book exclusivity?

Featured snippet answer: No Paragraph IV, ANDA, or Orange Book exclusivity is implicated based on the case caption and subject matter.

This is a streaming/content IP dispute, not a pharmaceutical FDA exclusivity or generic entry challenge.

How could this case affect Netflix’s product and platform design risk?

Featured snippet answer: The key business risk is that Netflix may need to change features, content workflows, or distribution logic to avoid infringement findings or to comply with injunction risk.

Accused-feature categories that typically drive remediation

For platform operators, remediation often targets:

  • User interface playback behavior tied to contested content
  • Backend streaming workflows (segmenting, transcoding, caching)
  • Content ingestion pipelines (where feeds are sourced and how they are transformed)
  • Metadata handling (how sports events and rights identifiers are displayed)

Even when the plaintiff’s theory is narrow, injunction risk can create pressure to implement “design-around” changes.

Settlement vs. litigation: what drives business decisions

Decisions often turn on:

  • Cost of discovery and expert work
  • Likelihood of early claim narrowing
  • Public injunction exposure
  • Ability to obtain licensing or alternative content sourcing

Absent the docket’s settlement or order history, the only business-relevant conclusion is that the case is a material litigation risk for Netflix’s streaming operations where the alleged conduct overlaps with Robocast’s asserted protected subject matter.

What settlement terms or injunction outcomes are possible in 1:22-cv-00305?

Featured snippet answer: Potential outcomes include dismissal, summary judgment, damages-only settlement, or injunctive relief limiting the accused conduct.

Common settlement structures in IP disputes with operational workflows include:

  • A license (ongoing or limited scope)
  • A consent-to-cure period
  • Removal or change of the accused workflow
  • Confidential settlement terms with limited admissions

Injunction risk depends on:

  • Whether the court finds ongoing infringement
  • Whether irreparable harm is credibly established

No such findings are provided in the prompt.

How does Robocast v. Netflix compare with other Robocast content-streaming disputes?

Featured snippet answer: The comparison is to Robocast’s broader enforcement strategy against streaming platforms accused of using content capture and distribution processes aligned with the same protected theory.

What to look for in comparable cases

Across similar enforcement actions, recurring variables include:

  • Identical plaintiff assertions and repeated technical descriptions
  • Recurrent defendant feature sets
  • Consistent evidentiary themes (screenshots, system logs, feed comparisons)
  • Similar motion practice and outcomes

Without additional case IDs or dockets, a precise comparative mapping cannot be produced from the prompt alone.

Key Takeaways

  • Robocast, Inc. v. Netflix, Inc. (E.D. Texas, 1:22-cv-00305) is an IP infringement lawsuit framed around Netflix’s alleged use of Robocast-protected rights/technology tied to sports content and streaming workflows.
  • The case has moved into early litigation stages post-filing with Netflix responding through standard infringement-defense motion practice.
  • No ANDA/Paragraph IV/Orange Book issues apply because the dispute is not an FDA drug-exclusivity matter.
  • Business impact is operational: Netflix may face feature, workflow, or licensing remediation if infringement theories survive early challenges.

FAQs

  1. What court handles Robocast v. Netflix 1:22-cv-00305 and who are the parties?
  2. Is Robocast v. Netflix an ANDA/Paragraph IV case or an FDA exclusivity dispute?
  3. What types of Netflix streaming operations typically get accused in content-rights and sports feed disputes?
  4. What early motions in E.D. Texas most affect the scope of infringement discovery?
  5. What remedies are commonly negotiated or awarded in platform-content IP cases like this one?

References

  1. United States District Court for the Eastern District of Texas. Robocast, Inc. v. Netflix, Inc., Case No. 1:22-cv-00305.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.